31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure

scientific article published on 01 August 1987

31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0002-9149(87)90233-5
P698PubMed publication ID3618489

P2093author name stringB M Massie
P Sleight
B Rajagopalan
J Ledingham
M Conway
G Radda
R Yonge
S Frostick
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectcongestive heart failureQ19000661
P304page(s)309-315
P577publication date1987-08-01
P1433published inAmerican Journal of CardiologyQ2208417
P1476title31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure
P478volume60

Reverse relations

cites work (P2860)
Q5758039831P MR spectroscopy and in vitro markers of oxidative capacity in type 2 diabetes patients
Q72064726Abnormalities of skeletal muscle metabolism during nerve stimulation determined by 31P nuclear magnetic resonance spectroscopy in severe congestive heart failure
Q36840489Abnormalities of skeletal muscle metabolism in patients with chronic heart failure: evidence that they are present at rest
Q54376722Alterations of skeletal muscle metabolism in humans studied by phosphorus 31 magnetic resonance spectroscopy in congestive heart failure
Q104583004Association of muscular fitness with rehospitalization for heart failure with reduced ejection fraction
Q39773232Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography
Q71867164Cardiopulmonary determinants of functional capacity in patients with chronic heart failure compared with normals
Q72563848Changes in intracellular pH during repeated exercise
Q37276462Detection of calf muscle alterations in patients with chronic heart failure by P magnetic resonance spectroscopy: Impaired adaptation to continuous exercise.
Q52017015Effects of chronic heart failure on skeletal muscle capillary hemodynamics at rest and during contractions
Q72265427Evaluation of myocardial energy status in vivo by NMR spectroscopy
Q41381394Exercise for patients with congestive heart failure
Q40457694Exercise intolerance in patients with chronic heart failure.
Q41187847Exercise limitation in chronic heart failure: central role of the periphery
Q71663025Factors which alter the relationship between ventilation and carbon dioxide production during exercise in normal subjects
Q33542801Growth hormone: a new therapy for heart failure?
Q36503403Heart failure: a model of cardiac and skeletal muscle energetic failure.
Q35965740Incremental large and small muscle mass exercise in patients with heart failure: evidence of preserved peripheral haemodynamics and metabolism
Q44436439Insulin signalling and resistance in patients with chronic heart failure
Q37945453Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning?
Q68471290Magnetic Resonance Muscle Studies: Implications for Psychiatry
Q30467992Magnetic resonance spectroscopy studies of human metabolism
Q46169257Morphologic features of the myopathy associated with chronic renal failure
Q35160336New aspects for the role of physical training in the management of patients with chronic heart failure
Q42578714Peripheral circulatory adaptations to pump failure of the heart
Q40702979Peripheral factors in the management of congestive heart failure
Q43910068Phosphorus-31 magnetic resonance spectroscopy of forearm flexor muscles in student rowers using an exercise protocol adjusted for differences in cross-sectional muscle area
Q71008952Physical deconditioning may be a mechanism for the skeletal muscle energy phosphate metabolism abnormalities in chronic heart failure
Q35742256Physiology of the abnormal response of heart failure patients to exercise
Q54957993Prolonged mean VO2 response time in systolic heart failure: an indicator of impaired right ventricular-pulmonary vascular function.
Q68498110Regional blood flow, muscle strength and skeletal muscle histology in severe congestive heart failure
Q42164949Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
Q28363148Role of phosphate and calcium stores in muscle fatigue
Q57422783Skeletal Muscle Function and Its Relation to Exercise Tolerance in Chronic Heart Failure
Q37994970Skeletal muscle abnormalities in chronic heart failure
Q71940602Skeletal muscle and the control of ventilation on exercise: evidence for metabolic receptors
Q36833411Skeletal muscle metabolism during exercise in patients with chronic heart failure
Q36836922Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis.
Q71606979Structure of skeletal muscle in heart transplant recipients
Q34639381The effect of neoadjuvant chemoradiotherapy on whole-body physical fitness and skeletal muscle mitochondrial oxidative phosphorylation in vivo in locally advanced rectal cancer patients--an observational pilot study
Q38708011The influence of iron deficiency on the functioning of skeletal muscles: experimental evidence and clinical implications
Q35313284Vasodilators. A re-evaluation of their role in heart failure
Q38801305V̇o2 kinetics associated with moderate-intensity exercise in heart failure: impact of intrathecal fentanyl inhibition of group III/IV locomotor muscle afferents
Q69450797[New research on muscular function: NMR spectroscopy. Application to malignant hyperthermia]
Q80953102[Physical rehabilitation of patients suffering from chronic heart failure]
Q67917293[Spectroscopy of phosphorus in nuclear magnetic resonance. General review of clinical applications to the study of human skeletal muscle]

Search more.